C4 Therapeutics CCCC 深 沪
已收盘 08-22 16:00:00 美东时间
2.61
0.000
0.00%
华盛通- 最 高2.755
- 今 开2.62
- 成交量 93.44万股
- 最 低 2.60
- 昨 收 2.61
- 总市值 1.85亿
- 52周最高 7.22
- 市盈率 静 --
- 换手率 1.32%
- 52周最低 1.085
- 委 比 39.66%
- 总股本 7100.71万
- 历史最高 51.21
- 量 比 0.59
- 振 幅 5.94%
- 历史最低 1.06
- 每 手 1
- 风险率 2.20%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股牛股 | Firefly航天上市首日飙涨34%！季报超预期，Sunrun、AVAH绩后股价集体大涨
Firefly航天上市首日大涨34%！总市值达85亿美元；Q2季报超预期，AVAH绩后飙涨49%，太阳能概念Sunrun大涨32%>>
08-08 15:45
C4 Therapeutics Q2 EPS $(0.37) Beats $(0.41) Estimate, Sales $6.463M Beat $5.240M Estimate
C4 Therapeutics (NASDAQ:CCCC) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.41) by 9.76 percent. This is a 42.31 percent decrease over losses of $(0.26) per share from
08-07 19:13
C4 Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
C4 Therapeutics reported positive updates on its cemsidomide Phase 1 trial in multiple myeloma, with an overall response rate of 40% at 75 µg and 50% at 100 µg. The trial data was accepted for an oral presentation at the International Myeloma Society (IMS) annual meeting. The company also held a productive Type C meeting with the FDA, refining its registrational development plans, targeting initiation in early 2026. Additionally, a preclinical mi...
08-07 11:00
东南亚第一长隧贯通，中国标准攻克世界级难题
近日 中交马东铁项目云顶2号隧道贯通 作为全线关键控制性工程 隧道全长16.39公里 是东南亚第一长隧 此次隧道贯通 打通了马来半岛地理屏障 实现马来西亚东西海...
07-17 18:56
C4 Therapeutics Board Member Bruce Downey Retires
C4 Therapeutics ( ($CCCC) ) has shared an announcement. On April 10, 2025, Bruc...
04-14 20:45
创新一哥的最大招，不是盈利
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 近日，JPM大会召开，诸多早已声名鹊起的pharma，biopharma和bi...
01-18 23:48
C4 Therapeutics gains after portfolio updates
Shares of C4 Therapeutics (NASDAQ:CCCC) traded higher on Tuesday after the cancer drug developer highlighted its upcoming milestones and updated its 2024 financials. Notable events expected from the W...
01-15 03:02
